BioNexus Gene Lab Corp Common stock (BGLC) Stock Analysis

Sector: BASIC MATERIALS - SPECIALTY CHEMICALS

Exchange: NASDAQ

Key Metrics

• Price: $2.55
• Market Cap: $5.97M
• EPS: $-1.28
• 52-Week High: $15.60
• 52-Week Low: $1.92

Market Sentiment

BioNexus Gene Lab Corp Common stock currently has a Bullish sentiment score of 0.45.

About BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp (BGLC) is a biotechnology firm based in Kuala Lumpur, Malaysia, dedicated to pioneering advancements in genetic research and innovative therapeutic solutions. Positioned at the forefront of the biotechnology sector, BGLC harnesses state-of-the-art gene editing and biomanufacturing methodologies to tackle critical healthcare challenges. The company boasts a promising product pipeline targeting improvements in human health and agricultural productivity, thereby capitalizi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for BioNexus Gene Lab Corp Common stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BGLC pay dividends?

BioNexus Gene Lab Corp Common stock (BGLC) does not currently pay a regular dividend.

What is BGLC's market cap?

BioNexus Gene Lab Corp Common stock (BGLC) has a market capitalization of $5.97M with a current stock price of $2.55.